| Classic Hodgkin Lymphoma studied in …STUDIED_INderived114 of 114show fewer |
|---|
| → studied in | NCT01896999Phase 1/Phase 2 · active not recruiting Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06377540Phase 2 · recruiting MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02940301Phase 2 · active not recruiting Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04561206Phase 2 · recruiting Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233347Phase 2 · active not recruiting Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05934084NA · recruiting Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06745076Phase 2 · recruiting Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05039073Phase 2 · recruiting Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04288726Phase 1 · active not recruiting Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05705531recruiting A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03150329Phase 1 · active not recruiting Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL. · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07021989Phase 2 · recruiting ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07275216Phase 2 · recruiting Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907488Phase 3 · active not recruiting Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02166463Phase 3 · active not recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05362773Phase 1 · active not recruiting A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05714553Phase 1/Phase 2 · terminated NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07720011Phase 2 · completed Interim PET/CT-adapted Use of PD-1 Inhibitor Combined With De-escalated Chemotherapy-AVD in Classic Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06164275Phase 2 · active not recruiting Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07572123Phase 2/Phase 3 · not yet recruiting Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02332668Phase 1/Phase 2 · recruiting A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04788043Phase 2 · terminated Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03697408Phase 1/Phase 2 · active not recruiting Itacitinib + Everolimus in Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04510636Phase 2 · recruiting Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07652476not yet recruiting Neurocognitive Assessment in Long-Term Survivors of Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05162976Phase 1 · active not recruiting CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or Relapsed · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06822855recruiting Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01476410Phase 2 · completed Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma · condition mapped ALIAS · 114 trials mapped (45 active) | — | — | Adult Mixed Cellularity Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07575893Phase 1 · not yet recruiting CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05404945Phase 2 · active not recruiting Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06870487Phase 1 · terminated A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07555210NA · recruiting Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03580564Phase 2 · completed An Open, Multicenter Phase II Study to Evaluate the Safety and Efficacy of KL-A167 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03057795Phase 2 · active not recruiting Nivolumab & Brentuximab Vedotin Consolidation After Autologous SCT in Patients With High-Risk Classical Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05949931Phase 2 · recruiting Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06617286Phase 1/Phase 2 · not yet recruiting CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03236935Phase 1 · completed Phase Ib of L-NMMA and Pembrolizumab · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02684708Phase 3 · completed Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06563245Phase 2/Phase 3 · recruiting Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03652441Phase 2 · completed Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04486391Phase 3 · terminated Tislelizumab Monotherapy Versus Salvage Chemotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04067037Phase 2 · active not recruiting Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02408861Phase 1 · terminated Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07356882recruiting European Project for ctDNA Detection as a Biomarker for Non-invasive Therapy Monitoring in Paediatric Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02815137NA · completed Detection and Prognostic Value of Recurrent XPO1 Mutations of Patients With Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05179603Phase 2 · terminated A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205] · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04074746Phase 1/Phase 2 · completed Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06018129Phase 1/Phase 2 · terminated A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04318080Phase 2 · completed Tislelizumab in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07171827NA · completed Anti-CD30 (Brentuximab Vedotin) With AVD Versus ABVD Chemotherapy Protocol Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02758717Phase 2 · active not recruiting Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01771107Phase 1/Phase 2 · completed Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03739619Phase 1/Phase 2 · completed Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03331341Phase 1/Phase 2 · completed Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05008224Phase 2 · completed Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06916416Phase 2 · not yet recruiting Phase II Trial of Anti-PD-1 Antibody Treatment and Radiotherapy in Early-stage Favorable Classic Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03004833Phase 2 · completed Nivolumab and AVD in Early-stage Unfavorable Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03480334Phase 2 · active not recruiting Abscopal Effect of Radiotherapy and Nivolumab in Relapsed Hodgkin Lymphoma After Anti-PD1 Therapy · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06857500completed Brentuximab Vedotin with Adriamycin, Vinblastine and Dacarbazine for Patients Aged 18-59 Years with Untreated Advanced-stage Classical Hodgkin Lymphoma: a Real-life Experience · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06848569Phase 2 · recruiting Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02824029Phase 2 · completed Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03190174Phase 1/Phase 2 · completed Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06642792Phase 1/Phase 2 · recruiting A Study of AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04254107Phase 1 · terminated A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814860completed Microenvironmental Trial of Classical Hodgkin Lymphoma in Adolescents · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03209973Phase 2 · completed A Study of Tislelizumab as Monotherapy in Relapsed or Refractory Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03212404Phase 1 · active not recruiting Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03712202Phase 2 · active not recruiting Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04838652Phase 2 · recruiting Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595866Phase 1 · completed Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04837859Phase 2 · recruiting Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06465446Phase 3 · not yet recruiting A Study of IMM01 Plus Tiselizumab Versus Physician's Choice Chemotherapy in PD(L)1-refractory Classical Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05955105Phase 1/Phase 2 · unknown A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02661503Phase 3 · unknown HD21 for Advanced Stages · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02981914early Phase 1 · completed Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05711628Phase 3 · withdrawn A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02168140Phase 1 · completed CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma · condition mapped ALIAS · 114 trials mapped (45 active) | — | — | Adult Mixed Cellularity Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858568completed Immune Responses to COVID-19 Vaccination in Lymphoma Patients · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06235047completed Liposomal Doxorubicin-containing Front-line Treatment in Elderly Patients With HL (HL-MVD) · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06190067Phase 2 · recruiting Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04187872Phase 1 · terminated LITT and Pembrolizumab in Recurrent Brain Metastasis · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03229278Phase 1 · completed Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04952584Phase 1 · withdrawn Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes in Relapsed or Refractory CD30-Positive Lymphomas · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05900765Phase 2 · unknown A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03077828Phase 2 · unknown Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Lymphocyte-Rich Classical Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03226249Phase 2 · unknown PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05833984Phase 1/Phase 2 · unknown Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05352828Phase 1 · active not recruiting Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03552003unknown Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05518318Phase 3 · unknown GLS-010 Monotherapy Versus Chemotherapy in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma (R/R cHL) · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04624984Phase 2 · unknown PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHL · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01535924Phase 1/Phase 2 · completed Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma · condition mapped ALIAS · 114 trials mapped (45 active) | — | — | Adult Mixed Cellularity Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03374007Phase 1 · unknown Phase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Lymphocyte-Depleted Classical Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03327571completed B-CD30 + Hodgkin Lymphoma International Multi-center Retrospective Study of Treatment Practices and Outcomes · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00302003Phase 3 · completed Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma · condition mapped ALIAS · 114 trials mapped (45 active) | — | — | Childhood Mixed Cellularity Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381940Phase 2 · completed Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy · condition mapped ALIAS · 114 trials mapped (45 active) | — | — | Adult Mixed Cellularity Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02414568Phase 2 · completed Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04342936Phase 3 · unknown Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03042247unknown Prospective Comparison Between FDG-PET/MR and FDG-PET/CT in Classical Hodgkin Lymphoma and DLBC Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00967369Phase 2 · completed Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment. · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02164500Phase 2 · completed JAK-inhibition in Recurrent Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00654732Phase 2 · completed Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03471351Phase 1 · terminated Safety and Efficacy Study of Tenalisib (RP6530) in Combination With Pembrolizumab in Relapsed or Refractory cHL · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03527628Phase 2 · unknown OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02243436Phase 1/Phase 2 · completed Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03205891Phase 1 · withdrawn Study of Brentuximab Vedotin Plus TAK228 for Relapsed/Refractory Classical Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma and Other CD30+Peripheral T-Cell Lymphomas · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01460940Phase 2 · completed A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma · condition mapped ALIAS · 114 trials mapped (45 active) | — | — | Adult Mixed Cellularity Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025259Phase 3 · completed Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease · condition mapped ALIAS · 114 trials mapped (45 active) | — | — | Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112723Phase 1/Phase 2 · terminated Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma · condition mapped ALIAS · 114 trials mapped (45 active) | — | — | Adult Mixed Cellularity Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02808520unknown Social Inequalities in the Participation and Activity in Children and Adolescents With Hodgkin-lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00082966Phase 2 · completed Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma · condition mapped ALIAS · 114 trials mapped (45 active) | — | — | Adult Mixed Cellularity Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00337194Phase 2 · completed SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma · condition mapped ALIAS · 114 trials mapped (45 active) | — | — | Adult Mixed Cellularity Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00132028Phase 2 · completed Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma · condition mapped ALIAS · 114 trials mapped (45 active) | — | — | Adult Mixed Cellularity Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00305149NA · completed Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma · condition mapped CURATED_BROADER · 114 trials mapped (45 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |